Association between total prostate-specific antigen (tPSA), free/tPSA, and prostate cancer mortality
- PMID: 35297160
- DOI: 10.1111/bju.15611
Association between total prostate-specific antigen (tPSA), free/tPSA, and prostate cancer mortality
Comment in
-
Reply to the letter by Ferraro and Biganzoli.BJU Int. 2022 Mar;129(3):419. doi: 10.1111/bju.15642. BJU Int. 2022. PMID: 35297161 No abstract available.
Comment on
-
Association between one-time prostate-specific antigen (PSA) test with free/total PSA ratio and prostate cancer mortality: A 30-year prospective cohort study.BJU Int. 2021 Oct;128(4):490-496. doi: 10.1111/bju.15417. Epub 2021 May 6. BJU Int. 2021. PMID: 33811738
References
-
- Lundgren PO, Kjellman A, Norming U, Gustafsson O. Association between one-time prostate-specific antigen (PSA) test with free/total PSA ratio and prostate cancer mortality: a 30-year prospective cohort study. BJU Int 2021; 128: 490-6
-
- Eriksson S, Vehniäinen M, Jansén T et al. Dual-label time-resolved immunofluorometric assay of free and total prostate-specific antigen based on recombinant Fab fragments. Clin Chem 2000; 46: 658-66
-
- Ferraro S, Bussetti M, Panteghini M. Serum prostate specific antigen (PSA) testing for early detection of prostate cancer: managing the gap between clinical and laboratory practice. Clin Chem 2021; 67: 602-9
-
- Foj L, Filella X, Alcover J, Augé JM, Escudero JM, Molina R. Variability of assay methods for total and free PSA after WHO standardization. Tumour Biol 2014; 35: 1867-73
-
- Ferraro S, Bussetti M, Rizzardi S, Braga F, Panteghini M. Verification of harmonization of serum total and free prostate-specific antigen (PSA) measurements and implications for medical decisions. Clin Chem 2021; 67: 543-53
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
